1. Home
  2. DLPN vs CUE Comparison

DLPN vs CUE Comparison

Compare DLPN & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.46

Market Cap

19.1M

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$34.73

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
CUE
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
17.6M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
DLPN
CUE
Price
$1.46
$34.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$120.00
AVG Volume (30 Days)
21.6K
21.2M
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
77.87
61.11
EPS
N/A
N/A
Revenue
$56,699,389.00
$27,466,000.00
Revenue This Year
$14.73
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.70
195.75
52 Week Low
$0.99
$0.17
52 Week High
$1.88
$38.00

Technical Indicators

Market Signals
Indicator
DLPN
CUE
Relative Strength Index (RSI) 49.65 83.39
Support Level $1.45 $0.40
Resistance Level $1.65 N/A
Average True Range (ATR) 0.07 4.84
MACD 0.01 3.12
Stochastic Oscillator 52.17 81.55

Price Performance

Historical Comparison
DLPN
CUE

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: